Skip to main content

Table 4 Multivariable overall survival analysis for 127 patients with CMML

From: Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia

Parameters

HR

95%CI

P value

Hb < 100 g/L vs ≥100 g/L

2.42

1.40–4.19

0.002

IMCs presence vs absence

2.08

1.25–3.46

0.005

ASXL1 mut vs wt

1.99

1.20–3.28

0.007